Context: Obesity poses a significant health risk, but health risk is not equivalent to actual health status. Further, age and gender might alter the effect of body weight on physical health. Objective: To determine the relationship between body mass index (BMI), age, gender and current health status. Design: Data from the 1988-1994, 2003-2004 and 2005-2006 National Health & Nutrition Examination Surveys were weighted to represent the US population. BMI, age, gender and current medication use were analyzed in a sample-adjusted 9071 women and 8880 men. Main Outcome Measures: The percentage of participants taking medication and the total number of medications taken. Results: In both the 1988-1994 and 2003-2006 data sets, with few exceptions, medication loads did not increase significantly in overweight compared with normal-weight people. Medication loads increased significantly in obese compared with normalweight people aged 40 þ , but only marginally at 25-39 years. Medication loads were higher in women than men, but significantly less so in people aged 55-70. Conclusions: First, medication loads, a measure of current health status, were increased in obese compared with the normalweight people, but the effect was mainly at ages over 40 years. In addition, BMI category contributed less to medication loads at ages 25-39 than in older groups. Second, there was little difference in current health status in normal-weight versus overweight people at all ages. Finally, higher medication loads in women than men are more apparent in younger than older people. Although obesity does not substantially affect current health in young people, it is likely that the increased medication loads in obese compared with normal-weight older people originates at least in part from an increased BMI starting at a younger age. Thus, age, gender and onset of high BMI all require consideration when using BMI to assess current health status.
Introduction
The prevalence of obesity has increased over the last 20 years. From 1988 From and 1994 From -1999 From and 2000 , for example, the age-adjusted prevalence of obesity in the United States increased from 22.9 to 30.5%. 1 Even in developing countries, the prevalence of obesity has increased, and worldwide more than 1.1 billion adults are overweight and 312 million are obese. 2 Unfortunately, numerous health complications are associated with obesity, making obesity a risk factor for a variety of diseases, including type 2 diabetes, hypertension and cardiovascular disease. 2 Obesity is also related to the metabolic syndrome, 3 a condition associated with increased risk of death from all causes, including cardiovascular disease. 4 In fact, based on 1991 data, approximately 300 000 deaths annually in the United States are attributable to obesity. 5 Although measuring mortality and future risk of disease are important in evaluating the relationship between body mass and health, the likelihood of death or becoming sick are not the only medical concerns; rather, it is also important to determine the relationship between body mass and current illness. For example, an obese person at age 30 may have high risk for future disease but low current illness, while at age 60 an obese person may have both high risk for later illness and high current illness.
Although generally accepted body mass index (BMI) cutoff points distinguishing between underweight, normal weight, overweight and obese do not differ for men and women, 3, 6 women may experience greater adverse health effects from obesity than do men, 7, 8 suggesting that the same BMI value may be associated with a different illness load depending on gender. Further complicating the relationship between BMI and illness is age. Aging itself is associated with an increased incidence of illness, 9 and some diseases are clearly age related. 10 Consequently, the same BMI value may carry a different illness load depending on age.
To better understand the relation between BMI, age, gender and current health, we evaluated data for women and men contained in the [1988] [1989] [1990] [1991] [1992] [1993] [1994] We used BMI scores from height and weight measurements obtained by NHANES staff, not from the height and weight reported by the NHANES participants. Although a BMI of 18.5 can be considered the beginning of the normal-weight range, we excluded all people with a BMI value lower than 19.5 to decrease the potential for confounding based on the increased prevalence of illness associated with being underweight. 13, 14, 15 As our focus is on adults, we excluded data from people o25 years of age. In addition, we excluded people older than age 70 because of controversy in the elderly regarding definitions for excessive weight and the effects of obesity on health, 3, 16, 17 to avoid introducing the confound whereby decreasing body weight could be associated with the increased incidence of illness that accompanies aging, 9 and because of reported weight loss in people after age 70, 18 a finding confirmed in this study by the fall in BMI values in women and men after approximately age 70 ( Figure 1 ). In that we wished to restrict our analysis to nonpsychiatric illnesses and because of known associations between many psychotropic drugs and weight gain, 19 we excluded medication use data in the NHANES 1988-1994 pertaining to the international classification of diseases, 9th revision (ICD-9) categories 290-319 (mental illnesses) and in the NHANES 2003-2006, the data pertaining to stimulant, anxiolytic, antidepressant, cholinesterase inhibiting, mood stabilizing, anticholinergic and antipsychotic medication identified by Lexicon Plus codes, a database used in the NHANES data sets to identify drugs. 20 As a result of the accepted use of valproate 21 and lamotrigine 22 to treat bipolar disorder, we also excluded these two medications from the analysis. We used participants' reports of prescribed medication use as an estimate for illness burden based on the assumption that the reported use of prescribed medication would represent diagnosed illness or symptoms thought serious enough to warrant treatment. More than one illness would be reflected by an increased number of reported medications. In short, we assumed that the percentage of people taking prescribed medication and the number of reported medicationsF'medication load'Fwould provide omnibus measures of illness burden. In the NHANES data sets, participants were asked directly regarding use of prescribed medication in the past month, including the number of prescription medications used. Interviewers then further asked to actually see the medication containers to verify the participants' reports.
To obtain medication load scores as a proxy for illness load, we used two broad approaches. The first was to analyze ) Â 100, where d was the fitted function. As the distribution for the number of medications was positively skewed because of the large number of people not taking any medication (scored as zeros), we performed zero-inflated Poisson regressions for this analysis. With this regression, the expected number of medications is generated by combining two processes in a mixed model, the result of a Bernoulli trial with a logistic link to determine which is used: process 1, which generates only zero counts with a probability y; and process 2, which generates the outcome from a Poisson model. 23 In process 1, the probability of an individual taking zero medications was given by y ¼ eŷ=ð1 þ eÞeŷ, whereŷ was the fitted function. In process 2, a Poisson portion gave probabilities for the number of medications, e b , given the overdispersion of zeros determined by process 1, and b was the fitted function. 23, 24 To further analyze BMI and age, we also ran 'categorical' logistic and zero-inflated Poisson regressions with the variables of interest being gender, weight category (normal weight, overweight, obese), and age group (25-39, 40-54, 55-70 years of age); effects were analyzed by calculating differences in the regression estimates between men and women, the weight categories, and the age groups.
Results
Body mass index values and medication load scores (Figure1  and Table 1 The main effects were significant in all of the above models: medication loads were greater for women than men
The influence of BMI, age and gender on current illness B Jarrett et al (t-values from 4.55 to 9.57, P-values o0.0001), increased with increasing BMI scores (t-values from 2.86 to 13.04, P-values o0.01), and increased with increasing age (t-values 7.25-23.10, P-values o0.0001). The Sex by Age interactions were significant in all of the models (t-values from 2.70 to 4.04, P-values p0.01). Further analysis of the Sex by Age interactions with Age and BMI as categorical variables showed that the interaction was primarily because of a significantly decreased sex difference in medication loads in people 55-70 years of age; this is illustrated for the number of medications and the percent medicated in Figure 2 . Although not significant for the number of medications, the Sex by BMI interaction was significant for the percentage taking medication (for NHANES 1988-1994 and 2003-2006, t-values were 3.76 and 2.30, respectively, P-values o0.05). It appeared that the effect was due to a decreased sex difference in the percentage taking medication in obese people, but the analysis with categorical variables revealed that this was significant only for NHANES [1988] [1989] [1990] [1991] [1992] [1993] [1994] .
For the regressions with categorical variables, a significant overall increase in medication loads in overweight versus normal-weight people was evident in only one of the four analysesFthe percent medicated in NHANES 2003-2006 (t ¼ 2.24, P ¼ 0.03). Correspondingly, the number of significant post hoc comparisons presented in Table 2 was significantly less in overweight versus normal-weight people (2 of 24) than in obese versus overweight and obese versus normalweight people (w 2 ¼ 8.17 and 21.67, respectively, P-values o0.01). All of the regressions revealed significant overall increases in medication loads in the older versus younger age groups (for the three comparisons, t-values from 2.54 to 8.17, P-values p0.01). However, when each age group was analyzed across weight categories in men and women separately, in contrast to the results in men and women at 40-54 and 55-70 years of age in which all tests were significant (P-values p0.02), at 25-39 years of age a majority of the tests (5 of 8) were not significant (P-values X0.18). Correspondingly, the number of significant post hoc comparisons presented in Table 2 was significantly less at 25-39 years of age (5 of 24) than at 40-54 and 55-70 years of age (w 2 ¼ 6.94 and 4.36, respectively, P-values o0.05). In addition, although all four regressions with categorical variables revealed significant overall increases in medication loads in normal-weight versus obese people (t-values from 2.54 to 8.17, P-values p0.01), the number of significant post hoc comparisons presented in Table 2 for normal-weight versus obese people was significantly less at 25-39 years of age (3 of 8) than at 40-54 and 55-70 years of age (w 2 ¼ 4.66, P-values o0.05). The influence of BMI, age and gender on current illness B Jarrett et al
Discussion
This study gives several findings. First, with few exceptions, in both data sets medication loads regardless of age group did not increase significantly in the overweight group compared with normal-weight people. Thus, being overweight by itself was not generally associated with an increased medication load. Second, BMI category contributed less to current medication loads in people aged 25-39 years than in older people. Third, medication loads increased in the obese group compared with normal-weight people, but the effect occurred mainly in people aged 40-54 and 55-70 years. Although the lack of association between BMI category and medication loads in the youngest age group is evidence that increased BMI does not substantially affect health in relatively young people, it is likely that an increased BMI requires time before it results in an increased medication loadFthat is, part of the increased medication loads in the obese compared with normal-weight groups observed in the older people may well originate in an increased body weight starting at a younger age. Additional research on the time of overweight or obesity onset is required to analyze these effects. Medication loads were higher in women than in men in both the NHANES 1988-1994 and 2003-2006 data sets, indicating a persistent effect that remained even while BMI and medication loads increased across the time period in both women and men. Although the higher medication loads in women is consistent with findings of higher symptoms of illness scores in women than men 11 and findings that obese and overweight women have measures indicative of greater illness (for example, lower healthrelated quality of life scores and higher numbers of health complaints) than do obese men, 7,8 the difference was more pronounced in people aged 25-39 and 40-54 years than in the group aged 55-70 years. Several possible reasons for sex differences in illness load have been suggested, including that women are more aware of their physical status, more readily perceive physical sensations as symptoms of disease, may have a greater propensity to report illness, and may be more susceptible to the effects of stress. [25] [26] [27] [28] [29] [30] [31] Alternatively, sex differences for which our study was not designed to identify might lead to a greater propensity for women than men to develop illness at a given BMI at a given age. For example, the BMI does not discriminate fat from muscle, 30 men can have more muscle than women, 7 and men have significantly higher lean body mass values than women during the younger ages of adulthood (20-50 years) but not the older ages, 31 all reasons why the same BMI score is not necessarily comparable between the sexes at all ages. The influence of BMI, age and gender on current illness B Jarrett et al However, the finding that the difference between women and men in medication loads diminishes in the group aged 55-70 years suggests that age requires consideration when assessing the differences in illness load between women and men. As mentioned, BMI and medication loads increased between the 1988-1994 and 2003-2006 periods. The increase in BMI scores, which occurred across all ages for both men and women, is consistent with the reported increase in BMI in the United States over the past 20 years.
1,2 Concerning medication loads, both the percentage of people taking medications and the number of medications taken increased between the 1988-1994 and 2003-2006 periods, but only in people aged 40-54 and 55-70 years, not in the younger age group. Although our study was not designed to study the causes of the increased use of medication, one possibility is an increased morbidity related to the increased BMI between the two periods; another is possible changes in physician prescribing patterns, such as more aggressive treatment. [32] [33] [34] [35] Several factors require consideration in interpreting the findings reported herein. The use of reported medications was only a proxy for actual illness load. However, the number of medications taken has been used by others to validate health questionnaires. 11, 12 In addition, the use of a large number of people and the similarity of the findings across the two time periods reinforce the stability of the present results, and the convergence of results from the percentage of participants taking medication and the total number of medications taken shows consistency across two health burden measures. The BMI does not discriminate fat from muscle as does, for example, the waist-to-hip ratio, which is a measure of abdominal fat. 27 Nonetheless, the BMI is widely used, and it has been helpful in studying the relationship between body weight and numerous health issues. 21 Our findings could be limited because several diseases such as hypertension and hyperlipidemia can be asymptomatic and may not have been diagnosed, resulting in an underestimate of illness load. Finally, caveats pertaining to cross-sectional studies in general apply to our findings as well. For example, factors associated with both BMI and medication use, such as socioeconomic status and level of physical activity, could act as confounders, and information bias could have affected our results. However, in the NHANES data, interviewers asked to see medication containers to verify the participants' reports, and BMI was obtained from measured heights and weights. The influence of BMI, age and gender on current illness B Jarrett et al
Conclusions
Using data from the NHANES 1988 NHANES -1994 NHANES and 2003 NHANES -2006 surveys to assess current health status as measured by medication load, we have found that medication loads were increased in the obese group compared with the normalweight group, but the effect was mainly in people over age 40. In addition, BMI category contributed less to current medication loads in people aged 25-39 years than it did in older people. Further, there was little difference between normal-weight and overweight people at all ages. Finally, higher medication loads in women than men were more apparent in younger than older people. Although the present results indicate increased BMI does not substantially affect current health in young people, it is likely that the increased medication loads in obese than normal-weight older people may at least partly originate in an increased BMI starting at a younger age. Thus, age and sex require consideration when using BMI to assess current health status, and onset of high BMI to assess health risk.
